{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:32:33Z","timestamp":1786739553545,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>Various vaccines against coronavirus disease 2019 (COVID-19) have been developed amidst the ongoing pandemic. Few cases of glomerulonephritis after COVID-19 vaccination have been reported globally. We present a case of nephrotic syndrome due to minimal change disease (MCD) most likely associated with the ChAdOx1 nCoV-19 vaccine. A 24-year-old male presented with anasarca and frothy urine after receiving the first dose of the COVID-19 vaccine. On admission, the patient had normal serum creatinine with 24-h urinary protein excretion of 4.1 g\/day and severe hypoalbuminemia. Kidney biopsy revealed nonproliferative glomerular morphology with relatively unremarkable-appearing glomeruli on light microscopy and diffuse effacement of the odocyte foot processes on electron microscopy, consistent with diagnosis of MCD. This case highlights the risk of new-onset nephrotic syndrome due to MCD after COVID-19 vaccination.<\/jats:p>","DOI":"10.4103\/jfmpc.jfmpc_1082_22","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T05:53:22Z","timestamp":1667973202000},"page":"6568-6570","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Minimal change disease (MCD) following vaccination with ChAdOx1 nCoV-19 vaccine in a young Indian male: A case report"],"prefix":"10.4103","volume":"11","author":[{"given":"Amresh","family":"Krishna","sequence":"first","affiliation":[{"name":"Department of Nephrology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prit Pal","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajit","family":"Mazumdar","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Renal Pathology and Electron Microscopy, National Reference Lab, Dr. Lal Pathlabs, Rohini, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"R1-20260527","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.ekir.2021.06.024","article-title":"Nephrotic syndrome following ChAdOx1 nCoV-19 vaccine against SARScoV-2","volume":"6","author":"Anupama","year":"2021","journal-title":"Kidney Int Rep"},{"key":"R2-20260527","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 Clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","year":"2021","journal-title":"Kidney Int"},{"key":"R3-20260527","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2:An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"R4-20260527","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-20260527","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12882-020-01970-y","article-title":"Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease:A report of 2 cases","volume":"21","author":"Gupta","year":"2020","journal-title":"BMC Nephrol"},{"key":"R6-20260527","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/1319-2442.270254","article-title":"Vaccine-associated kidney diseases:A narrative review of the literature","volume":"30","author":"Patel","year":"2019","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R7-20260527","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.3346\/jkms.2021.36.e218","article-title":"New-onset nephrotic syndrome after Janssen COVID-19 vaccination:A case report and literature review","volume":"36","author":"Lim","year":"2021","journal-title":"J Korean Med Sci"},{"key":"R8-20260527","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.ajkd.2021.03.010","article-title":"Minimal change disease following the Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Lebedev","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"R9-20260527","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.kint.2021.05.007","article-title":"Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine","volume":"100","author":"Holzworth","year":"2021","journal-title":"Kidney Int"},{"key":"R10-20260527","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.ajkd.2021.05.003","article-title":"An additional case of minimal change disease following the Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Maas","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"R11-20260527","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.kint.2021.04.035","article-title":"Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine","volume":"100","author":"D'Agati","year":"2021","journal-title":"Kidney Int"},{"key":"R12-20260527","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.kint.2021.06.005","article-title":"Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine","volume":"100","author":"Morlidge","year":"2021","journal-title":"Kidney Int"},{"key":"R13-20260527","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.ekir.2021.07.017","article-title":"Report of three cases of minimal change disease following the second dose of mRNA SARS-CoV-2 COVID-19 vaccine","volume":"6","author":"Salem","year":"2021","journal-title":"Kidney Int Rep"},{"key":"R14-20260527","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00467-017-3677-5","article-title":"Immunology of idiopathic nephrotic syndrome","volume":"33","author":"Colucci","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"R15-20260527","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1128\/JVI.00266-10","article-title":"Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus","volume":"84","author":"Miao","year":"2010","journal-title":"J Virol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1082_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:29:58Z","timestamp":1786735798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1082_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1082_22","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"2022-05-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}